Structure -activity relationships (SAR) between modified eremophilanes and anti-inflammatory activity are reported. The compounds have shown antioxidant (DPPH model), hypoglycaemic, antihyperglucemic and antidiabetic effects in rats.
Modified eremophilanes (Figure 1) , which constitute the most numerous group of eremophilanes (sesquiterpenes) that contain a furanic ring, are widely distributed in plants of several genera, for example Euryops, Ligularia, Psacalium, and Senecio, amongst others belonging to the family Asteraceae [1] . The common structural characteristics of all the members of this class of natural products are: a tricyclic system of decalin [2,3-b] furan, two methyl groups syn in the atoms of carbon C-4 and C-5, and a methyl group at C-13. Additionally, they can present diverse degrees of oxidation in several positions of the decalinic system, preferring the cis orientation [1] . Some modified eremophilanes have been found to have bioactivity, and have been reported as anti-microbial, germination inhibitor, anti-fungal, allelopathic, antihyperglycemic, hypoglycemic, antioxidant and anti-inflammatory agents [2] [3] [4] [5] [6] [7] .
The genus Psacalium (Asteraceae, Senecio, Tussilagininae) includes 47 species distributed from the Southwest USA to Guatemala. Previous chemical studies have shown that the eremophilanes are the principal secondary metabolites elaborated by species of this genus. P. decompositum (Cacalea decomposita) [8] , P. palmeri, P. peltatum, P. sinuatum, P. radulifolium and Acourtia thurberi have been grouped by the local population of the north of Mexico as the Matarique complex [9] , and used for the treatment of rheumatism and diabetes, as well as for renal, hepatic and gastrointestinal diseases [10] . P. radulifolium is the most common substitute for P. decompositum in the Matarique complex in the region of San Luis Potosí, México [9] .
The modified eremophilanes studied in this work, previously isolated from roots of P. radulifolium, were: O-methyl-1,2-dehydrocacalol (1), decompostin (2), neoadenostylone (3), maturinone (4), a 1:1 mixture of cacalone (5) and epi-cacalone (6), radulifolin D (7), radulifolin F (8), epi-radulifolin F (9), cacalol (10), adenostilone A (11), radulifolin A (12), epi-radulifolin A (13), radulifolin B (14) , radulifolin C (15), acetylmaturine (16) , dimaturine (17) , hydroxyl-cacalolide (18) , epi-hydroxycacalolide (19) and radulifolin E (20) [11] [12] .
The main purpose of this work was to study the influence of electronic and steric properties on the anti-inflammatory activity of eight modified eremophilanes isolated from roots of P. radulifolium, in order to elucidate their mechanism of action as anti-inflammatory agents.
Recognizing the influence of the electronic and steric properties already shown by the evaluated compounds in the TPA mouse ear edema model, we can suggest the possible activity of other modified eremophilanes isolated from P. radulifolium and other plants.
A structure-activity relationship (SAR) model has been developed for modified eremophilanes. The model is based on the physicochemical properties of twenty modified eremophilanes, from which eight were tested in the TPA mouse edema ear model, and the physicochemical parameters that represent electronic and steric properties were calculated for each compound. Additionally, we made the calculations for another twelve modified eremophilanes isolated from the roots of P. radulifolium.
The results of the present study demonstrated the anti-inflammatory activity that some modified eremophilanes present under experimental animal model used, these results indicate that physicochemical features of modified eremophilanes compounds contribute to anti-inflammatory activity.
From Table 1 , we can see that natural mixture of 5 and 6 presents the highest anti-inflammatory activity, followed by compounds 4 and 7, and finally, compounds 1, 2, 3 and 8 present low antiinflammatory activities. Recently, cacalone (5) and cacalol (10) were reported to have dose dependent anti-inflammatory activity using in vivo models [13] .
The optimized structures of twenty compounds were obtained. We also calculated the molecular properties and found them to be correlated with the antiinflammatory activity presented by the modified eremophilanes under study. Eight of the compounds were used in an experimental model to evaluate their anti-inflammatory activity; their optimized structures are shown in Figure 2 .
In Table 1 are shown the obtained values for the electronic and steric properties of all the compounds studied in this work. When we analyzed the steric properties of compounds that produce a high percentage of edema inhibition, we could see that area, volume and molecular mass are important properties to explain the anti-inflammatory activity presented by the compound studied.
Analyzing the calculated total (E T ) energy (Table 1) of the eight eremophilanes assayed, we can see that the compounds have similar values for this property, and the optimized structures have similar chemical stability.
The E HOMO and E LUMO values were calculated because these properties can give an idea of the electrondonating and electron-accepting character of a compound and, consequently, an idea of the probability of a charge transfer complex (CTC) being formed.
The energy measurements of these properties give information about electron-donating and electronaccepting; when the value of the E HOMO is higher, the more electron-donating is the character of the compound, and when the value of the E LUMO is lower the more electron-accepting character the compound has [14] [15] [16] [17] [18] [19] .
Using the obtained information, we classified the modified eremophilanes as "evaluated" after they were experimentally demonstrated to possess anti-inflammatory activity. These compounds showed the highest E HOMO values, which were similar among them, whereas the E LUMO values present relevant differences. The E LUMO values obtained for the "evaluated" compounds were analyzed. We decided to investigate the LUMO plots (which are presented in Figure 3 ) of the "evaluated" compounds as antiinflammatory agents. From Figure 3 , we can see that the atomic contributions for LUMO are similar for compounds 2, 3, 4, 5, 6 and 8. The atomic contributions are spread along the furanic ring. However, comparing the LUMO plots (Figure 3 ) of the "evaluated" compounds, we can see that compounds 4, 5, 6 and 7, which have the highest activity, present the atomic contributions for LUMO basically from the furanic ring, indicating that these are essential for the anti-inflammatory activity.
On the other hand, compounds 2, 3 and 8 also have the atomic contribution for LUMO from the furanic ring, but they have less anti-inflammatory activity; this was attributed to the steric impediment presented in these eremophilane molecules. It is important to notice that the most active compounds (4, 5, 6 and 7) do not present such steric impediment. Therefore, the presence of substituent groups in the compound structure probably causes the decrease of its antiinflammatory activity.
From Table 1 we can see that the E T values of the active compounds are lower than those of compounds without anti-inflammatory activity. On the other hand, the HF values of the active compounds are more positive than those of the inactive compounds.
Finally, μ is not a property associated with the biological effect obtained for modified eremophilanes, because this property does not correlate with the anti-inflammatory activity, according to the results obtained in this study.
Analyzing the calculated steric properties A, MM and VOL (Table 1) , we can see that the active compounds have similar values for these and have lower values than the inactive compounds; consequently, these properties are associated with the observed antiinflammatory activity.
With the analysis of the minimal energy conformations of the compounds under study, it is observed that the presence of the furanic ring and that of the carbonyl group at C-9 are indispensable for the anti-inflammatory activity. Both groups are pharmacophoric points that generate an important constraint and they are hydrogen bond acceptors. On the other hand, analyzing the steric properties of these compounds, we can conclude that significant anti-inflammatory activity is shown by the eremophilane compounds without additional substituents in ring A. In this way, we can select compounds with specific structural characteristics to bind with the receptor, even though they do not relate to the affinity or nature of its activity (as an agonist or an antagonist), such as in the case of the mixture of compounds 5 and 6, where the substituents in position 6 do not interfere with the anti-inflammatory activity observed, since they do not take part in the pharmacophore.
We can conclude that the natural mixture of 5 and 6 presents the highest anti-inflammatory activity and compounds 1, 2, 3 and 8 the lowest. Structural (A, MM and VOL), electronic (E LUMO ) and steric (presence of substituent groups) aspects can be relevant features to be considered for understanding the relationship between the modified eremophilanes, and their anti-inflammatory activity, and the furanic ring and that of the carbonyl group in C-9 are pharmacophoric points that generate important constraints.
Further evaluation of compounds such as inhibitors of COX-1, COX-2 and cPLA 2 to recognize the selectivity are in progress.
Experimental

Chemicals:
The modified eremophilanes studied in this work were previously isolated from roots of Psacalium radulifolium [11] [12] .
Computer software: The geometries of the compounds studied in this work were modeled using the molecular mechanics method MM+ [20, 21] for pre-optimization, followed by the performed conformational analysis, and the molecular properties calculated by the AM1 method, both by Hyper Chem Pro 6.0 program [22] .
Molecular properties of chemical compounds can be correlated with biological activity data and this correlation is called structure-activity relationship (SAR) [23] [24] [25] [26] [27] . SAR methods have been used successfully in pharmaceutical applications and in this work we calculated some molecular properties of modified eremophilanes in order to correlate them with their anti-inflammatory activity. The calculated descriptors were selected so that they could represent electronic and steric proprieties of the compounds studied, as they are supposed to be important for their anti-inflammatory activity.
Regression analyses identified significant models (p < 0.05). The calculated descriptors were: Electronic properties: E T (total energy), HF (heat of formation), E HOMO (the highest occupied molecular orbital energy), E LUMO (the lowest unoccupied molecular orbital energy), μ (dipole moment), and steric properties: A (surface area), MM (molecular mass) and VOL (molecular volume).
Animals:
Female BALB/c mice were used at ages from 6 to 8 weeks. The animals had free access to food and water and were kept on a 12/12 h light-dark cycle.
TPA-induced mouse ear edema:
Mouse ear edema was evaluated following the protocol previously described [28] , using groups of three female Balb/c mice. Edema was induced by topical application of 2.5 μg per ear of TPA dissolved in EtOH. Solutions of the compounds (1 mg/ear) and the standard drug indomethacin (1 mg/ear), as reference, were dissolved in different solvents according to their solubility and were applied to both sides of the right ear (10 μL each side) simultaneously with TPA. The ear swelling was measured before TPA application and 4 h after, and the edema was expressed as the increase in thickness.
